PGA TOUR Partner Cialis(R) (tadalafil) Debuts 2005 Consumer Golf Plans at The Ford Championship at Doral
28 Februar 2005 - 3:00PM
PR Newswire (US)
PGA TOUR Partner Cialis(R) (tadalafil) Debuts 2005 Consumer Golf
Plans at The Ford Championship at Doral -- New Vignettes, The Golf
Channel Partnership and Enhanced Web Site Unveiled -- MIAMI, Feb.
28 /PRNewswire-FirstCall/ -- Cialis(R) (tadalafil), the erectile
dysfunction drug marketed by Lilly ICOS
(NYSE:LLYNYSE:andNYSE:Nasdaq:NYSE:ICOS), debuted an updated
multi-faceted golf program today at the Ford Championship at Doral
to inspire golf aficionados to relax and enjoy the game more. Now
in the second season of its PGA TOUR partnership, Cialis has
created a range of national and local initiatives designed to
enhance the golf experience both on and off the course. Improving
on last year's "Memorable Moments" broadcast vignettes, 12 new
Cialis-sponsored vignettes featuring prominent PGA TOUR players
will provide glimpses into their lives "outside the office" and
reinforce the importance of relaxation in preparing for rounds. The
first vignette will air during the Ford Championship at Doral, and
additional vignettes will continue to roll out throughout the
season. "We want to help golfers remember that relaxation is a
fundamental aspect of the game and encourage them to take the
lessons they learn on the green and apply them to their lives off
the course," explained Matt Beebe, Cialis U.S. Brand Team Leader.
"By offering golf fans the chance to look into the life of PGA TOUR
players away from the course with the vignettes, we hope to
reinforce the message that relaxation is key to enjoying and
succeeding in golf." Cialis will also be conducting some new
activities in cooperation with The Golf Channel. At select
tournaments, including the Ford Championship at Doral, golfers can
enjoy a complimentary swing analysis by PGA of America teaching
professionals at the Cialis fan tent titled "The Golf Channel Swing
Experience Presented by Cialis." The Golf Channel will feature some
of the swings on Monday nights throughout the season during its
themed lineup of programs designed for game improvements known as
"Your Game Night." Additional national and local components of
Cialis' PGA TOUR partnership include: * Branded Scoreboards: Cialis
branded scoreboards will appear at 60 PGA TOUR and Champions TOUR
tournaments throughout the season. * Web site: The Cialis-sponsored
interactive Web site at http://www.cialis.pgatour.com/ provides
tips on how to relax and enjoy one's golf game more, while also
letting visitors view vignettes. Visitors can get specific advice
on the mental aspects of the game from leading experts in golf and
sports psychology. Additional components include on-line survey
questions, a listing of tournaments with a Cialis on-site presence,
and description of "The Golf Channel Swing Experience Presented by
Cialis." * Cialis Tent: At select tournaments, including Ford
Championship at Doral, golfers can help improve their golf games
both on and off the course. After participating in "The Golf
Channel Swing Experience Presented by Cialis," each golfer will
receive a personalized video golf lesson (or Web lesson) that
outlines the individual swings, lesson notes and drills based on
the swing analysis captured on video in the tent. Targeting the
"other" side of the game, golf fans can gain insight from sports
psychologist Dr. Rick Jensen and cardiologist Dr. Ed Palank who
have designed tips focusing on the mental, emotional, and physical
approach to the game. Cialis Golf Program Cialis is an official
partner of both the PGA TOUR and Champions Tour through 2007 and
title sponsor of the Cialis Western Open through 2006. According to
Lilly ICOS, the sponsorship represents a timely and unique
opportunity to educate men in the United States about a significant
health issue -- erectile dysfunction (ED) -- and the role of Cialis
as the only oral ED treatment shown to improve erectile function
for up to 36 hours in most men. Through its partnership with the
PGA TOUR, Lilly ICOS offers consumers information about ED and
Cialis on-site in the Cialis tent. Consumers may pick up brochures
on ED or Cialis, and access the Cialis Web site,
http://www.cialis.com/ , to get more information about Cialis.
About Cialis Cialis, approved by the FDA in November 2003 for the
treatment of erectile dysfunction, is the only oral ED treatment
shown to improve erectile function up to 36 hours in most men.
Cialis can be taken without regard to food. The absorption of
Cialis is not reduced by food, including high-fat foods. Cialis is
currently available in approximately 100 countries, including
Australia, Brazil, Mexico, Canada, the United States and countries
throughout Europe. More than 3.5 million patients worldwide have
been treated with Cialis since its first introduction in February
2003. Cialis is available by prescription only and is not for
everyone. Men taking nitrates, often used for chest pain, or
certain alpha-blockers for prostate problems or high blood
pressure, should not take Cialis. Such combinations could cause a
sudden, unsafe drop in blood pressure. Men should discuss their
health status with their doctors to ensure Cialis is right for them
and that they are healthy enough for sexual activity. The most
common side effects with Cialis were headache, upset stomach,
delayed backache or muscle ache. Although rare, men who experience
an erection for more than four hours should seek immediate medical
attention. Men should not drink alcohol in excess with Cialis.
Cialis does not protect a man or his partner from sexually
transmitted diseases, including HIV. Individual results may vary.
Cialis studies were not designed to assess multiple intercourse
attempts after a single dose. For full patient information, visit
http://www.cialis.com/ . About Lilly ICOS LLC Lilly ICOS LLC, a
joint venture between ICOS Corporation (NASDAQ:ICOS) and Eli Lilly
and Company (NYSE:LLY), developed tadalafil for the treatment of
erectile dysfunction. ICOS Corporation, a biotechnology company
headquartered in Bothell, Washington, is dedicated to bringing
innovative therapeutics to patients. ICOS is marketing its product,
Cialis (tadalafil), through Lilly ICOS LLC. ICOS is working to
develop treatments for serious unmet medical conditions such as
chronic obstructive pulmonary disease, benign prostatic
hyperplasia, cancer and inflammatory diseases. Lilly, a leading
innovation-driven corporation is developing a growing portfolio of
first-in-class and best-in-class pharmaceutical products by
applying the latest research from its own worldwide laboratories
and from collaborations with eminent scientific organizations.
Headquartered in Indianapolis, Ind., Lilly provides answers --
through medicines and information -- for some of the world's most
urgent medical needs. Additional information about Lilly is
available at http://www.lilly.com/ . P-LLY About the PGA TOUR The
PGA TOUR is a tax-exempt membership organization of professional
golfers. Its primary purpose is to provide competitive earnings
opportunities for past, current and future members of the PGA TOUR,
Champions Tour and Nationwide Tour; to protect the integrity of the
game; and to help grow the reach of the game in the U.S. and around
the world. Nearly 110 events will be contested on the three Tours
in 2005, for approximately $320 million in prize money. In addition
to providing competitive opportunities for its membership, TOUR
events also generate significant sums of money for charity. TOUR
events have raised more than $900 million for charity since 1938,
the first year such records were kept. The PGA TOUR's Web site
address is http://www.pgatour.com/ . Except for historical
information contained herein, this press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements are based on current expectations, estimates and
projections about the industry, management beliefs and certain
assumptions made by the management of ICOS and Lilly. Investors are
cautioned that matters subject to forward-looking statements
involve risks and uncertainties, including economic, competitive,
governmental, technological, legal and other factors discussed in
the two companies' respective filings with the Securities and
Exchange Commission, which may affect the business and prospects of
the two companies and Lilly ICOS. Results and the timing and
outcome of events may differ materially from those expressed or
implied by the forward-looking statements in this press release.
More specifically, there can be no assurance that Cialis will
achieve commercial success or that competing products will not
pre-empt market opportunities that might exist for the product.
Cialis(R) is a registered trademark of Lilly ICOS LLC. Other
trademarks are the property of their respective owners. (Photo:
http://www.newscom.com/cgi-bin/prnh/20040311/PGATOURLOGO
http://www.newscom.com/cgi-bin/prnh/20040122/LILLYICOSLOGO )
http://www.newscom.com/cgi-bin/prnh/20040311/PGATOURLOGO
http://www.newscom.com/cgi-bin/prnh/20040122/LILLYICOSLOGO
DATASOURCE: Lilly ICOS LLC CONTACT: Kindra Strupp of Lilly ICOS,
+1-317-277-5170; or Chris Smith of PGA TOUR, +1-904-273-3379
Copyright